Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Radiopharmaceuticals"" wg kryterium: Temat


Starter badań:

Tytuł:
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
Autorzy:
Kryza D; Hospices Civils de Lyon, Lyon, France. .; UNIV Lyon-Université Claude Bernard Lyon 1, LAGEPP UMR 5007 CNRS Villeurbanne, Villeurbanne, 69100, France. .; Centre de médecine nucléaire Lumen, 15 rue Gabriel Sarrazin, cedex 08, Lyon, 69373, France. .
Vinceneux A; Department of Medical Oncology, Centre Leon Bérard, Lyon, France.
Bidaux AS; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Garin G; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Tatu D; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Cropet C; Department of Biostatistics, Centre Leon Berard, Lyon, France.
Badel JN; Lumen Nuclear Medicine Department, Centre Léon Bérard, Lyon, France.
Perol D; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Giraudet AL; Lumen Nuclear Medicine Department, Centre Léon Bérard, Lyon, France. .; Centre de médecine nucléaire Lumen, 15 rue Gabriel Sarrazin, cedex 08, Lyon, 69373, France. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 01; Vol. 24 (1), pp. 163. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/radiotherapy
Carcinoma, Renal Cell*/drug therapy
Lutetium*/adverse effects
Lutetium*/therapeutic use
Radioisotopes*/adverse effects
Radioisotopes*/therapeutic use
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/radiotherapy
Antigens, Surface*/metabolism
Glutamate Carboxypeptidase II*/antagonists & inhibitors
Radiopharmaceuticals*/adverse effects
Radiopharmaceuticals*/therapeutic use
Humans ; Male ; Dipeptides/adverse effects ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/adverse effects ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prospective Studies ; Quality of Life ; Treatment Outcome ; Tumor Microenvironment ; Female ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy.
Autorzy:
Yang H; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Zeng X; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Liu J; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Li J; PET Center, Department of Nuclear Medicine, School of Medicine, The First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Li Y; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Zhang Q; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Shu L; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Liu H; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Wang X; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Liang Y; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
Hu J; HTA Co., Ltd., No. 1 Sanqiang Road, Fangshan District, Beijing, 102413, China.
Huang L; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China. .
Guo Z; State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China. .
Zhang X; Theranostics and Translational Research Center, Institute of Clinical Medicine & Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 10; Vol. 22 (1), pp. 101. Date of Electronic Publication: 2024 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Radiopharmaceuticals*
Colorectal Neoplasms*/pathology
Male ; Animals ; Mice ; Gallium Radioisotopes ; Tissue Distribution ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Challenges and barriers of using large language models (LLM) such as ChatGPT for diagnostic medicine with a focus on digital pathology - a recent scoping review.
Autorzy:
Ullah E; Anatomical Pathology, Department of Pathology and Laboratory Medicine, Te Toka Tumai Auckland, Te Whatu Ora (Health New Zealand), Auckland, New Zealand.
Parwani A; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Baig MM; Health Intelligence, Orion Health, Auckland, New Zealand.
Singh R; Director of Dermatopathology and Digital Pathology, Summit Health, Woodland Park, NJ, USA. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Feb 27; Vol. 19 (1), pp. 43. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Language*
Radiopharmaceuticals*
Humans ; Databases, Factual
Czasopismo naukowe
Tytuł:
Scandium Radioisotopes-Toward New Targets and Imaging Modalities.
Autorzy:
Kilian K; Heavy Ion Laboratory, University of Warsaw, Pasteura 5a, 02-093 Warsaw, Poland.
Pyrzyńska K; Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 19; Vol. 28 (22). Date of Electronic Publication: 2023 Nov 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Radiopharmaceuticals*/therapeutic use
Radiopharmaceuticals*/chemistry
Scandium*/chemistry
Radioisotopes/therapeutic use ; Radioisotopes/chemistry ; Precision Medicine
Czasopismo naukowe
Tytuł:
[ F-Labelling in Hydrous Conditions-Towards a Microfluidic Synthesis of PET Radiopharmaceuticals.
Autorzy:
Ovdiichuk O; Nancyclotep, Molecular Imaging Platform, 54500 Vandoeuvre-les-Nancy, France.
Lahdenpohja S; Université Paris Saclay, CEA Inserm, CNRS, BioMaps, 91401 Orsay, France.
Béen Q; Nancyclotep, Molecular Imaging Platform, 54500 Vandoeuvre-les-Nancy, France.
Tanguy L; PMB-Alcen, 13790 Peynier, France.
Kuhnast B; Université Paris Saclay, CEA Inserm, CNRS, BioMaps, 91401 Orsay, France.
Collet-Defossez C; Nancyclotep, Molecular Imaging Platform, 54500 Vandoeuvre-les-Nancy, France.; Université de Lorraine, Inserm, IADI, 54000 Nancy, France.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Dec 26; Vol. 29 (1). Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Fluorides*
Radiopharmaceuticals*
Microfluidics ; Positron-Emission Tomography ; Cyclotrons
Czasopismo naukowe
Tytuł:
Fully Automated Production of [ Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets.
Autorzy:
Fonseca AI; ICNAS Pharma, University of Coimbra, 3004-531 Coimbra, Portugal.
Alves VH; ICNAS Pharma, University of Coimbra, 3004-531 Coimbra, Portugal.; Fluidomica, Lda., 3060-197 Cantanhede, Portugal.
Hrynchak I; ICNAS Pharma, University of Coimbra, 3004-531 Coimbra, Portugal.
Alves F; CIBIT/ICNAS, Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3004-531 Coimbra, Portugal.; Instituto Politécnico de Coimbra, ESTeSC-Coimbra Health School, 3045-093 Coimbra, Portugal.
Abrunhosa AJ; ICNAS Pharma, University of Coimbra, 3004-531 Coimbra, Portugal.; CIBIT/ICNAS, Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3004-531 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 12; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Gallium Radioisotopes*
Radiopharmaceuticals*
Cyclotrons ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł:
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy.
Autorzy:
Souche C; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.
Fouillet J; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.
Rubira L; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.
Donzé C; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.
Deshayes E; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University Montpellier, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Fersing C; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), University Montpellier, 34298 Montpellier, France.; IBMM, University Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Radiopharmaceuticals*/therapeutic use
Adenocarcinoma*
Humans ; Diphosphonates/therapeutic use ; Radioisotopes ; Zoledronic Acid
Czasopismo naukowe
Tytuł:
Development and Characterization of Tc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer.
Autorzy:
Bolzati C; Institute of Condensed Matter Chemistry and Energy Technologies, Consiglio Nazionale delle Ricerche, Corso Stati Uniti 4, 35127 Padova, Italy.
Gobbi C; Institute of Condensed Matter Chemistry and Energy Technologies, Consiglio Nazionale delle Ricerche, Corso Stati Uniti 4, 35127 Padova, Italy.
Ferro-Flores G; Laboratorio Nacional de Investigación y Desarrollo de Radiofármacos, Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N. La Marquesa, Ocoyoacac 52750, Mexico.
Turato S; Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.
Ocampo-Garcia B; Laboratorio Nacional de Investigación y Desarrollo de Radiofármacos, Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N. La Marquesa, Ocoyoacac 52750, Mexico.
Carpanese D; Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.
Marzano C; Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy.
Spolaore B; Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via Marzolo 5, 35131 Padova, Italy.
Fracasso G; Dipartimento di Scienze Biomediche, Università degli Studi di Padova, Viale G. Colombo 3, 35131 Padova, Italy.
Rosato A; Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.; Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche, Università degli Studi di Padova, Via Gattamelata 64, 35138 Padova, Italy.
Meléndez-Alafort L; Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64, 35138 Padova, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Radiopharmaceuticals*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Male ; Tomography, Emission-Computed, Single-Photon ; Antibodies ; Immunoglobulin Fragments
Czasopismo naukowe
Tytuł:
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of Lu-PSMA-617 in prostate cancer patients.
Autorzy:
Siebinga H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Privé BM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Peters SMB; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1060-1071. Date of Electronic Publication: 2023 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiopharmaceuticals*/pharmacokinetics
Radiopharmaceuticals*/therapeutic use
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Male ; Humans ; Dipeptides ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł:
Targeted Alpha-Particle Therapy: A Review of Current Trials.
Autorzy:
Jang A; Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Kendi AT; Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Johnson GB; Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Halfdanarson TR; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Sartor O; Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 19; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/drug therapy
Radiopharmaceuticals*/pharmacology
Humans ; Male ; Alpha Particles/therapeutic use ; Clinical Trials as Topic
Czasopismo naukowe
Tytuł:
First-in-Human PET Imaging of [ F]SDM-4MP3: A Cautionary Tale.
Autorzy:
Desmond KL; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Ontario, Canada.
Lindberg A; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Garcia A; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Tong J; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Harkness MB; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Dobrota E; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Smart K; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Ontario, Canada.
Uribe C; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Meyer JH; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Ontario, Canada.
Houle S; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Ontario, Canada.
Strafella AP; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Krembil Brain Institute, University Health Network, University of Toronto, Ontario, Canada.
Li S; PET Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut, USA.
Huang Y; PET Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut, USA.
Vasdev N; Azrieli Centre for Neuro-Radiochemistry & Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Molecular imaging [Mol Imaging] 2023 Sep 08; Vol. 2023, pp. 8826977. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiopharmaceuticals*
Positron-Emission Tomography*
Humans ; Animals ; Rats ; Tissue Distribution
Czasopismo naukowe
Tytuł:
A Study of the Bisphosphonic Derivatives from the Pudovik Reaction of Dialkyl α-Oxophosphonates and >P(O)H Reagents: X-ray Structure and Bioactivity.
Autorzy:
Szalai Z; Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Tóth B; Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Szabó RO; Eötvös Loránd Research Network (ELKH), Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.; Department of Genetics, Cell and Immunobiology, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary.
Bősze S; Eötvös Loránd Research Network (ELKH), Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.
Karaghiosoff K; Department Chemie, Ludwig-Maximilians-Universitat München, Butenandtstr. 5-13, D-81377 München, Germany.
Czugler M; Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Drahos L; MS Proteomics Research Group, Research Centre for Natural Sciences, 1117 Budapest, Hungary.
Keglevich G; Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Aug 12; Vol. 28 (16). Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Radiopharmaceuticals*
X-Rays ; Radiography ; Tetrazolium Salts ; Diethylamines
Czasopismo naukowe
Tytuł:
NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review.
Autorzy:
Trencsényi G; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Nagyerdei St. 98, H-4032 Debrecen, Hungary.
Enyedi KN; ELKH-ELTE Research Group of Peptide Chemistry, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.; Institute of Chemistry, Faculty of Science, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.
Mező G; ELKH-ELTE Research Group of Peptide Chemistry, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.; Institute of Chemistry, Faculty of Science, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary.
Halmos G; Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, Nagyerdei St. 98, H-4032 Debrecen, Hungary.
Képes Z; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Nagyerdei St. 98, H-4032 Debrecen, Hungary.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 11; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Radiopharmaceuticals*
Endothelial Cells*
Animals ; CD13 Antigens ; Cardiovascular Physiological Phenomena ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
Synthesis and Evaluation of Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.
Autorzy:
Luna-Gutiérrez M; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Cruz-Nova P; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Jiménez-Mancilla N; Cátedras, CONACyT, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Oros-Pantoja R; Faculty of Medicine, Universidad Autónoma del Estado de México, Toluca 50180, Mexico.
Lara-Almazán N; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Santos-Cuevas C; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Azorín-Vega E; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ocampo-García B; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ferro-Flores G; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 03; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
Radiopharmaceuticals*/therapeutic use
B7-H1 Antigen*
Mice ; Animals ; Tissue Distribution ; Benzene ; Neoplasm Micrometastasis ; Spectroscopy, Fourier Transform Infrared ; Tumor Microenvironment ; Lutetium/therapeutic use ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
First-in-human imaging using [ C]MDTC: a radiotracer targeting the cannabinoid receptor type 2.
Autorzy:
Du Y; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Coughlin JM; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA.
Brosnan MK; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Chen A; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Shinehouse LK; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Abdallah R; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Lodge MA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Mathews WB; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Liu C; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Wu Y; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Minn I; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Finley P; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Hall AW; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Lesniak WG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Dannals RF; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Horti AG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA. .; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2386-2393. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*/pharmacokinetics
Adult ; Humans ; Animals ; Mice ; Reproducibility of Results ; Positron-Emission Tomography/methods ; Brain/diagnostic imaging ; Brain/metabolism ; Receptors, Cannabinoid/metabolism
Czasopismo naukowe
Tytuł:
Recent Advances in Cu-Based Radiopharmaceuticals.
Autorzy:
Krasnovskaya OO; Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Abramchuck D; Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Erofeev A; Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.; Research Laboratory of Biophysics, National University of Science and Technology (MISIS), Leninskiy Prospect 4, 119049 Moscow, Russia.
Gorelkin P; Research Laboratory of Biophysics, National University of Science and Technology (MISIS), Leninskiy Prospect 4, 119049 Moscow, Russia.
Kuznetsov A; Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Leninskie Gory, 1, Bld. 2, 119991 Moscow, Russia.; Department of Physics, Lomonosov Moscow State University, Leninskie Gory, 1/2, 119991 Moscow, Russia.
Shemukhin A; Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Leninskie Gory, 1, Bld. 2, 119991 Moscow, Russia.
Beloglazkina EK; Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 23; Vol. 24 (11). Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Radiopharmaceuticals*/chemistry
Neoplasms*/diagnostic imaging
Neoplasms*/radiotherapy
Humans ; Copper ; Positron-Emission Tomography/methods ; Tomography, Emission-Computed, Single-Photon
Czasopismo naukowe
Tytuł:
[ F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT 1A receptors in humans.
Autorzy:
Courault P; Université Claude Bernard Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center, Lyon, France.; Hospices Civils de Lyon (HCL), Lyon, France.
Lancelot S; Université Claude Bernard Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center, Lyon, France.; Hospices Civils de Lyon (HCL), Lyon, France.; CERMEP, Bron, France.
Costes N; Université Claude Bernard Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center, Lyon, France.; CERMEP, Bron, France.
Colom M; Hospices Civils de Lyon (HCL), Lyon, France.
Le Bars D; Hospices Civils de Lyon (HCL), Lyon, France.; CERMEP, Bron, France.
Redoute J; CERMEP, Bron, France.
Gobert F; Université Claude Bernard Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center, Lyon, France.; Hospices Civils de Lyon (HCL), Lyon, France.
Dailler F; Hospices Civils de Lyon (HCL), Lyon, France.
Isal S; Hospices Civils de Lyon (HCL), Lyon, France.
Iecker T; CERMEP, Bron, France.
Newman-Tancredi A; Neurolixis, Castres, France.
Merida I; CERMEP, Bron, France.
Zimmer L; Université Claude Bernard Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center, Lyon, France. .; Hospices Civils de Lyon (HCL), Lyon, France. .; CERMEP, Bron, France. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 May; Vol. 50 (6), pp. 1651-1664. Date of Electronic Publication: 2023 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Radiopharmaceuticals*/metabolism
Serotonin*/metabolism
Animals ; Humans ; Male ; Young Adult ; Adult ; Reproducibility of Results ; Positron Emission Tomography Computed Tomography ; Brain/diagnostic imaging ; Brain/metabolism ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł:
Biodistribution and dosimetry for combined [ Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging.
Autorzy:
Delker A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. .
Schleske M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Liubchenko G; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Berg I; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Zacherl MJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; SyNergy, University of Munich, Munich, Germany.; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.
Gildehaus FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Rumiantcev M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Resch S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Hürkamp K; Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, 85764, Neuherberg, Germany.
Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Ziegler SI; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Böning G; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Apr; Vol. 50 (5), pp. 1280-1290. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms, Castration-Resistant*/diagnostic imaging
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Radiopharmaceuticals*/therapeutic use
Humans ; Male ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Isotopes ; Prostate-Specific Antigen ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon
Czasopismo naukowe
Tytuł:
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Autorzy:
Chisholm, Julia (AUTHOR)
Mandeville, Henry (AUTHOR)
Adams, Madeleine (AUTHOR)
Minard-Collin, Veronique (AUTHOR)
Rogers, Timothy (AUTHOR)
Kelsey, Anna (AUTHOR)
Shipley, Janet (AUTHOR)
van Rijn, Rick R. (AUTHOR)
de Vries, Isabelle (AUTHOR)
van Ewijk, Roelof (AUTHOR)
de Keizer, Bart (AUTHOR)
Gatz, Susanne A. (AUTHOR)
Casanova, Michela (AUTHOR)
Hjalgrim, Lisa Lyngsie (AUTHOR)
Firth, Charlotte (AUTHOR)
Wheatley, Keith (AUTHOR)
Kearns, Pamela (AUTHOR)
Liu, Wenyu (AUTHOR)
Kirkham, Amanda (AUTHOR)
Rees, Helen (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Mar2024, Vol. 16 Issue 5, p998. 24p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies